{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:41:38Z","timestamp":1779324098109,"version":"3.51.4"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T00:00:00Z","timestamp":1654128000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> Stress ulcer prophylaxis (SUP) prescribed in patients admitted to surgical wards with a low risk of stress-related mucosal disease (SRMD) accounted for a considerable proportion of improper use of proton pump inhibitors (PPIs). This study aimed to analyze the appropriateness of SUP prescribing patterns and identify its associated factors in the orthopedics department of a tertiary hospital in the Northwestern China.<\/jats:p><jats:p><jats:bold>Methods:<\/jats:bold> In this cross-sectional study, information regarding the demographic and clinical characteristics of 1,200 fracture inpatients who underwent surgical operations from January 2020 to August 2021 were collected from medical records. Established criteria were used to assess the appropriateness of the prescribing pattern for SUP, and the incidence of inappropriate SUP medication was calculated. Logistic regression analyses were used to identify factors associated with inappropriate SUP medication.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> Approximately, 42.4% of the study population was interpreted as inappropriate prescription of SUP. A total of 397 (33.1%) patients received SUP without a proper indication (overprescription), and the incidence of inappropriate SUP medication was calculated to be 43.11 per 100 patient-days. In addition, 112 (9.3%) inpatients for whom SUP was indicated did not receive SUP (underprescription). PPIs were prescribed in 96.1% of the inpatients who used acid suppression therapy (AST), and intravenous PPIs accounted for 95.3% thereof. In a multivariate logistic regression analysis, age above 65\u00a0years and prolonged hospitalization were associated with overprescription of SUP. Increased number of drugs excluding PPIs, the concurrent use of systemic corticosteroids, comorbidity of hypertension, and unemployed or retired status in inpatients were associated with a reduced likelihood of overprescription for SUP. Conversely, prolonged hospitalization, the concurrent use of systemic corticosteroids or anticoagulants, and unemployed status in inpatients were positively associated with underprescription of SUP.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> There was a high prevalence of inappropriate SUP prescription among noncritically ill inpatients of fracture who underwent surgical operations. We delineated the associated factors with inappropriate SUP medication, which indicated that more information was required for clinicians about rationality and efficiency of their prescribing practices. Effective intervention strategies should be executed by clinical pharmacists to reduce improper SUP medication.<\/jats:p>","DOI":"10.3389\/fphar.2022.881063","type":"journal-article","created":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:06:38Z","timestamp":1654167998000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Appropriateness and Associated Factors of Stress Ulcer Prophylaxis for Surgical Inpatients of Orthopedics Department in a Tertiary Hospital: A Cross-Sectional Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Haiyan","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoni","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyao","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaorong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1365-2036.2006.03226.x","article-title":"Predictors of Inappropriate Utilization of Intravenous Proton Pump Inhibitors","volume":"25","author":"Afif","year":"2007","journal-title":"Aliment. Pharmacol. Ther."},{"key":"B2","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1093\/ajhp\/61.6.588","article-title":"Stress Ulcer Prophylaxis in the Postoperative Period","volume":"61","author":"Allen","year":"2004","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B3","doi-asserted-by":"publisher","first-page":"101","DOI":"10.3109\/00365528509095839","article-title":"Prophylaxis and Management of Stress Ulcers","volume":"110","author":"Anderberg","year":"1985","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"B4","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/ajhp\/56.4.347","article-title":"ASHP Commission on Therapeutics and Approved by the ASHP Board of Directors on November 14, 1998","volume":"56","year":"1999","journal-title":"Am. J. Health Syst. Pharm."},{"key":"B5","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nrgastro.2014.235","article-title":"Stress-related Mucosal Disease in the Critically Ill Patient","volume":"12","author":"Bardou","year":"2015","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/j.1365-2753.2012.01838.x","article-title":"Stress Ulcer Prophylaxis in Non-Critically Ill Patients: a Prospective Evaluation of Current Practice in a General Surgery Department","volume":"19","author":"Bez","year":"2013","journal-title":"J. Eval. Clin. Pract."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2890","DOI":"10.1111\/j.1572-0241.2008.02216.x","article-title":"ACCF\/ACG\/AHA 2008 Expert Consensus Document on Reducing the Gastrointestinal Risks of Antiplatelet Therapy and NSAID Use","volume":"103","author":"Bhatt","year":"2008","journal-title":"Am. J. Gastroenterol."},{"key":"B8","first-page":"3392","article-title":"Consensus Review for Stress Ulcer Prophylaxis and Treatment (2018 Edition)","volume":"98","author":"Bo","year":"2018","journal-title":"Natl. Med. J. China"},{"key":"B9","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.amjmed.2015.02.014","article-title":"Impact of a Clinical Pharmacist Stress Ulcer Prophylaxis Management Program on Inappropriate Use in Hospitalized Patients","volume":"128","author":"Buckley","year":"2015","journal-title":"Am. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4483","DOI":"10.6039\/j.issn.1001-0408.2017.32.05","article-title":"Analysis of the Rationality of Perioperative PPIs in the Prevention of Stress Ulcer in Orthopedics Department of Our Hospital","volume":"28","author":"Chu","year":"2017","journal-title":"China Pharm."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1056\/NEJMra1605507","article-title":"Prophylaxis against Upper Gastrointestinal Bleeding in Hospitalized Patients","volume":"378","author":"Cook","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1056\/NEJM199402103300601","article-title":"Risk Factors for Gastrointestinal Bleeding in Critically Ill Patients. Canadian Critical Care Trials Group","volume":"330","author":"Cook","year":"1994","journal-title":"N. Engl. J. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1093\/qjmed\/hcq019","article-title":"Inappropriate Utilization of Intravenous Proton Pump Inhibitors in Hospital Practice-Aa Prospective Study of the Extent of the Problem and Predictive Factors","volume":"103","author":"Craig","year":"2010","journal-title":"QJM"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2561","DOI":"10.2169\/internalmedicine.49.4064","article-title":"Patterns and Predictors of Proton Pump Inhibitor Overuse Among Academic and Non-Academic Hospitalists","volume":"49","author":"Eid","year":"2010","journal-title":"Intern Med."},{"key":"B15","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/bmj.39406.449456.BE","article-title":"Overprescribing Proton Pump Inhibitors","volume":"336","author":"Forgacs","year":"2008","journal-title":"BMJ"},{"key":"B16","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1016\/s0140-6736(94)91843-0","article-title":"Risk of Upper Gastrointestinal Bleeding and Perforation Associated with Individual Non-steroidal Anti-inflammatory Drugs","volume":"343","author":"Garc\u00eda Rodr\u00edguez","year":"1994","journal-title":"Lancet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2200","DOI":"10.1111\/j.1572-0241.2006.00839.x","article-title":"Magnitude and Economic Impact of Inappropriate Use of Stress Ulcer Prophylaxis in Non-ICU Hospitalized Patients","volume":"101","author":"Heidelbaugh","year":"2006","journal-title":"Am. J. Gastroenterol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1007\/s11606-012-2296-x","article-title":"Risk Factors for Nosocomial Gastrointestinal Bleeding and Use of Acid-Suppressive Medication in Non-Critically Ill Patients","volume":"28","author":"Herzig","year":"2013","journal-title":"J. Gen. Intern Med."},{"key":"B19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1001\/archinternmed.2011.14","article-title":"Acid-suppressive Medication Use and the Risk for Nosocomial Gastrointestinal Tract Bleeding","volume":"171","author":"Herzig","year":"2011","journal-title":"Arch. Intern Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1097\/SMJ.0b013e3181f6539d","article-title":"Why Do Physicians Prescribe Stress Ulcer Prophylaxis to General Medicine Patients?","volume":"103","author":"Hussain","year":"2010","journal-title":"South Med. J."},{"key":"B21","doi-asserted-by":"publisher","first-page":"2633","DOI":"10.1007\/s10620-012-2104-9","article-title":"Variables Associated with Stress Ulcer Prophylaxis Misuse: a Retrospective Analysis","volume":"57","author":"Issa","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1111\/ggi.12047","article-title":"Prescribing Patterns of Proton Pump Inhibitors in Older Hospitalized Patients in a Scottish Health Board","volume":"13","author":"Jarchow-Macdonald","year":"2013","journal-title":"Geriatr. Gerontol. Int."},{"key":"B23","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/ajg.2013.108","article-title":"Risk of Gastrointestinal Bleeding in Patients Undergoing Total Hip or Knee Replacement Compared with Matched Controls: a Nationwide Cohort Study","volume":"108","author":"Lalmohamed","year":"2013","journal-title":"Am. J. Gastroenterol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/00003246-199901000-00034","article-title":"National Survey of Stress Ulcer Prophylaxis","volume":"27","author":"Lam","year":"1999","journal-title":"Crit. Care Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1038\/ajg.2009.115","article-title":"Guidelines for Prevention of NSAID-Related Ulcer Complications","volume":"104","author":"Lanza","year":"2009","journal-title":"Am. J. Gastroenterol."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.11569\/wcjd.v25.i24.2181","article-title":"Off-Label Use of Proton Pump Inhibitors","volume":"25","author":"Lei","year":"2017","journal-title":"World Chin. J. Digestol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1186\/s12913-018-3358-5","article-title":"Changes in Proton Pump Inhibitor Prescribing Trend over the Past Decade and Pharmacists' Effect on Prescribing Practice at a Tertiary Hospital","volume":"18","author":"Luo","year":"2018","journal-title":"BMC Health Serv. Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.6039\/j.issn.1001-0408.2018.12.30","article-title":"Investigation and Rationality Evaluation of Proton Pump Inhibitors Use in Our Hospital during Perioperative Period","volume":"29","author":"Ma","year":"2018","journal-title":"China Pharm."},{"key":"B29","doi-asserted-by":"publisher","first-page":"46958018759116","DOI":"10.1177\/0046958018759116","article-title":"A Successful Pharmacist-Based Quality Initiative to Reduce Inappropriate Stress Ulcer Prophylaxis Use in an Academic Medical Intensive Care Unit","volume":"55","author":"Masood","year":"2018","journal-title":"Inquiry"},{"key":"B30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/1319-3767.33463","article-title":"Improper Use of Antisecretory Drugs in a Tertiary Care Teaching Hospital: an Observational Study","volume":"13","author":"Mayet","year":"2007","journal-title":"Saudi J. Gastroenterol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3748\/wjg.v16.i8.982","article-title":"Clinical and Cost Impact of Intravenous Proton Pump Inhibitor Use in Non-ICU Patients","volume":"16","author":"Nasser","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"B32","volume-title":"National Health Commission Office Notification on Guidelines for Clinical Application of Proton Pump Inhibitors","year":"2020"},{"key":"B33","first-page":"544","article-title":"Investigation in the Use of PPI for Preventing SU in Orthopaedic Surgery","volume":"24","author":"Ruan","year":"2015","journal-title":"Chin. J. Pharmacoepidemiol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1016\/j.dld.2018.07.004","article-title":"Appropriateness in Prescribing Ppis: A Position Paper of the Italian Society of Gastroenterology (Sige) \u2014 Study Section \u201cDigestive Diseases in Primary Care\u201d","volume":"50","author":"Savarino","year":"2018","journal-title":"Dig. Liver Dis."},{"key":"B35","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1007\/s12603-015-0642-5","article-title":"Inappropriate Use of Proton Pump Inhibitors in Elderly Patients Discharged from Acute Care Hospitals","volume":"20","author":"Schepisi","year":"2016","journal-title":"J. Nutr. Health Aging"},{"key":"B36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1308\/rcsann.2016.0106","article-title":"Prophylactic Proton Pump Inhibitors in Femoral Neck Fracture Patients - A Life - and Cost-Saving Intervention","volume":"98","author":"Singh","year":"2016","journal-title":"Ann. R. Coll. Surg. Engl."},{"key":"B37","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1002\/agm2.12063","article-title":"Who Has the Guts to Deprescribe Proton Pump Inhibitors? A Pharmacist-Led Intervention in a Long-Term Care Facility Setting","volume":"2","author":"Tandun","year":"2019","journal-title":"Aging Med. Milt."},{"key":"B38","doi-asserted-by":"publisher","first-page":"652","DOI":"10.17235\/reed.2015.3882\/2015","article-title":"Reasons for Initiation of Proton Pump Inhibitor Therapy for Hospitalised Patients and its Impact on Outpatient Prescription in Primary Care","volume":"107","author":"Villama\u00f1\u00e1n","year":"2015","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"B39","doi-asserted-by":"publisher","first-page":"7591045","DOI":"10.1155\/2019\/7591045","article-title":"Predictors of Inappropriate Proton Pump Inhibitors Use in Elderly Patients","volume":"2019","author":"Voukelatou","year":"2019","journal-title":"Curr. Gerontol. Geriatr. Res."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2019-0306","article-title":"Analysis of the Use and Cost of Stress Ulcer Prophylaxis for Surgical Inpatients","volume":"30","author":"Wijaya","year":"2020","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"B41","first-page":"530","article-title":"Investigation and Analysis of Perioperative PPIs in the Prevention of Stress Ulcer in Orthopedics Department of Our Hospital","volume":"28","author":"Yao","year":"2019","journal-title":"Chin. J. Pharmacoepidemiol"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.881063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,2]],"date-time":"2022-06-02T11:06:48Z","timestamp":1654168008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2022.881063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,2]]},"references-count":41,"alternative-id":["10.3389\/fphar.2022.881063"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2022.881063","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,2]]},"article-number":"881063"}}